IPCA Laboratories Q3 FY24 Results Live : profit rise by 66.8% YOY
IPCA Laboratories declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 32.79% & the profit increased by 66.8% YoY.
As compared to the previous quarter the revenue grew by 0.93% and the profit increased by 24%. The Selling, general & administrative expenses rose by 7.79% q-o-q & increased by 44.15% Y-o-Y.
The operating income was up by 0.39% q-o-q & increased by 55.29% Y-o-Y. The EPS is ₹6.99 for Q3 FY24 which increased by 64.51% Y-o-Y.
IPCA Laboratories has delivered -5.78% return in the last 1 week, 29.79% return in last 6 months and 3.73% YTD return. Currently the IPCA Laboratories has a market cap of ₹29295.23 Cr and 52wk high/low of ₹1263.95 & ₹669.8 respectively.
As of 16 Feb, 2024 out of 14 analysts covering the company, 2 analysts have given Strong Sell rating, 3 analysts have given Sell rating, 5 analysts have given Hold rating, 2 analysts have given Buy rating &2 analysts have given Strong Buy rating. The consensus recommendation as on 16 Feb, 2024 was to Hold.FAQsQuestion : What is the Q3 FY24 profit/Loss as per company?Ans : ₹179.88CrQuestion : What is Q3 FY24 revenue?Ans : ₹2052.86Cr Stay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
